Precigen is trading 5.15% up now at $7.36, with no clear company-specific announcement identified on September 16, 2026.
- Latest identified results were released August 4; the next listed investor event is September 18.
- The advance appears more consistent with broader market strength: the Nasdaq is up 0.57%, while biotechnology is under pressure.
- This explanation is provisional because trading-volume data and a direct catalyst were unavailable.